Log In
Print
BCIQ
Print
Print this Print this
 

AzaSite

Also known as: ISV-401

  Manage Alerts
Collapse Summary General Information
Company InSite Vision Inc.
Description1% azithromycin with InSite's DuraSite ophthalmic drug delivery system
Molecular Target Ribosomal 50S subunit
Mechanism of Action 
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentMarketed
Standard IndicationConjunctivitis
Indication DetailsTreat acute bacterial conjunctivitis; Treat bacterial conjunctivitis
Regulatory Designation

Partner

Akorn Inc.; Nicox S.A.; Pfizer Inc.; Senju Pharmaceutical Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today